The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects
Open accessAbstract
Curcumin (a polyphenolic compound in turmeric) is famous for its potent anti-inflammatory, anti-oxidant, and anti-cancer properties, and has a great potential to act as an epigenetic modulator. The epigenetic regulatory roles of curcumin include the inhibition of DNA methyltransferases (DNMTs), regulation of histone modifications via the regulation of histone acetyltransferases (HATs) and histone deacetylases (HDACs), regulation of microRNAs (miRNA), action as a DNA binding agent and interaction with transcription factors. These mechanisms are interconnected and play a vital role in tumor progression. The recent research has demonstrated the role of epigenetic inactivation of pivotal genes that regulate human pathologies such as cancers. Epigenetics helps to understand the mechanism of chemoprevention of cancer through different therapeutic agents. In this regard, dietary phytochemicals, such as curcumin, have emerged as a potential source to reverse epigenetic modifications and efficiently regulate the expression of genes and molecular targets that are involved in the promotion of tumorigenesis. The curcumin may also act as an epigenetic regulator in neurological disorders, inflammation, and diabetes. Moreover, curcumin can induce the modifications of histones (acetylation/deacetylation), which are among the most important epigenetic changes responsible for altered expression of genes leading to modulating the risks of cancers. Curcumin is an effective medicinal agent, as it regulates several important molecular signaling pathways that modulate survival, govern anti-oxidative properties like nuclear factor E2-related factor 2 (Nrf2) and inflammation pathways, e.g., nuclear factor kappa B (NF-κB). Curcumin is a potent proteasome inhibitor that increases p-53 level and induces apoptosis through caspase activation. Moreover, the disruption of 26S proteasome activity induced by curcumin through inhibiting DYRK2 in different cancerous cells resulting in the inhibition of cell proliferation opens up a new horizon for using curcumin as a potential preventive and treatment approach in proteasome-linked cancers. This review presents a brief summary of knowledge about the mechanism of epigenetic changes induced by curcumin and the potential effects of curcumin such as anti-oxidant activity, enhancement of wound healing, modulation of angiogenesis and its interaction with inflammatory cytokines. The development of curcumin as a clinical molecule for successful chemo-prevention and alternate therapeutic approach needs further mechanistic insights.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ali, S., Ahmad, A., Banerjee, S., Padhye, S., Dominiak, K., Schaffert, J. M., Wang, Z., Philip, P. A., & Sarkar, F. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4598 · Cited by 424
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 2,998
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
Many roads to maturity: microRNA biogenesis pathways and their regulation
Winter, J., Jung, S., Keller, S., Gregory, R. I., & Diederichs, S. (2009) · Nature Cell Biology · doi:10.1038/ncb0309-228 · Cited by 2,656
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
Surh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Dose escalation of a curcuminoid formulation
Lao, C. D., Ruffin, M. T., Normolle, D., Heath, D. D., Murray, S. I., Bailey, J. M., Boggs, M. E., Crowell, J., Rock, C. L., & Brenner, D. E. (2006) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-6-10 · Cited by 1,394
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Nitric Oxide Scavenging by Curcuminoids
Sreejayan, & Rao, M. N. A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06761.x · Cited by 1,135
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
Motterlini, R., Foresti, R., Bassi, R., & Green, C. J. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00294-x · Cited by 846
Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832
Biological activities of Curcuma longa L.
Araújo, C., & Leon, L. (2001) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762001000500026 · Cited by 766
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.05.004 · Cited by 762
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710
Surh, Y.-J. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s1383-5742(99)00057-5 · Cited by 633
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., & Price, J. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1192 · Cited by 584
Huang, M., Lysz, T. W., Ferraro, T., Abidi, T. F., Laskin, D. L., & Conney, A. H. (1991) · PubMed · Cited by 571
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570
Renoprotective effect of the antioxidant curcumin: Recent findings
Trujillo, J., Chirino, Y. I., Molina-Jijón, E., Andérica-Romero, A. C., Tapia, E., & Pedraza-Chaverrí, J. (2013) · Redox Biology · doi:10.1016/j.redox.2013.09.003 · Cited by 566
Bharti, A. C., Donato, N., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3863 · Cited by 508
Rahman, I., Marwick, J., & Kirkham, P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.042 · Cited by 507
DNA minor-groove recognition by small molecules (up to 2000)
Neidle, S. (2001) · Natural Product Reports · doi:10.1039/a705982e · Cited by 494
Dermal wound healing processes with curcumin incorporated collagen films
Gopinath, D., Ahmed, M. R., Gomathi, K., Chitra, K., Sehgal, P. K., & Jayakumar, R. (2004) · Biomaterials · doi:10.1016/s0142-9612(03)00625-2 · Cited by 490
Shishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459
Curcuminoids as Potent Inhibitors of Lipid Peroxidation
Sreejayan, & Rao, M. N. A. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03258.x · Cited by 459
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., & Aggarwal, B. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204997 · Cited by 441
The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
Jiang, T., Huang, Z., Lin, Y., Zhang, Z., Fang, D., & Zhang, D. D. (2010) · Diabetes · doi:10.2337/db09-1342 · Cited by 440
Morimoto, T., Sunagawa, Y., Kawamura, T., Takaya, T., Wada, H., Nagasawa, A., Komeda, M., Fujita, M., Shimatsu, A., Kita, T., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33160 · Cited by 423
Thiyagarajan, M., & Sharma, S. S. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.06.042 · Cited by 416
Sun, M., Estrov, Z., Ji, Y., Coombes, K. R., Harris, D. H., & Kurzrock, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2272 · Cited by 412
Curcumin Is an In Vivo Inhibitor of Angiogenesis
Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M.-T., Fisher, C., Flynn, E., & Byers, H. R. (1998) · Molecular Medicine · doi:10.1007/bf03401744 · Cited by 402
Bayet-Robert, M., Kwiatowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Mouret-Reynier, M.-A., Durando, X., Barthomeuf, C., & Chollet, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10392 · Cited by 399
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system
Bech-Otschir, D. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1630 · Cited by 397
Clinical Outcomes and Correlates of TP53 Mutations and Cancer
Robles, A. I., & Harris, C. C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001016 · Cited by 394
Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin
Chen, Y.-R., & Tan, T.-H. (1998) · Oncogene · doi:10.1038/sj.onc.1201941 · Cited by 392
Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation
Pruitt, K., Zinn, R. L., Ohm, J. E., McGarvey, K. M., Kang, S.-H. L., Watkins, D. N., Herman, J. G., & Baylin, S. B. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020040 · Cited by 387 · cited 1×
“Previous studies also supported these findings as the induction of expression in respective genes has been observed in methylated promoters (Pruitt et al., 2006; Raynal et al., 2012).”
ResultEnhancement of wound healing by curcumin in animals
Sidhu, G. S., Singh, A. K., Thaloor, D., Banaudha, K. K., Patnaik, G. K., Srimal, R. C., & Maheshwari, R. K. (1998) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1998.60211.x · Cited by 372
Cathepsin L Proteolytically Processes Histone H3 During Mouse Embryonic Stem Cell Differentiation
Duncan, E. M., Muratore-Schroeder, T. L., Cook, R. G., Garcia, B. A., Shabanowitz, J., Hunt, D. F., & Allis, C. D. (2008) · Cell · doi:10.1016/j.cell.2008.09.055 · Cited by 364
Ryu, H., Smith, K., Camelo, S. I., Carreras, I., Lee, J., Iglesias, A. H., Dangond, F., Cormier, K. A., Cudkowicz, M. E., H. Brown, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03077.x · Cited by 353
Chemotherapy of human African trypanosomiasis: current and future prospects
Fairlamb, A. H. (2003) · Trends in Parasitology · doi:10.1016/j.pt.2003.09.002 · Cited by 342
Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer
Mudduluru, G., George-William, J. N., Muppala, S., Asangani, I. A., Kumarswamy, R., Nelson, L. D., & Allgayer, H. (2011) · Bioscience Reports · doi:10.1042/bsr20100065 · Cited by 332
Curcumin is a potent DNA hypomethylation agent
Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P.-K., Lin, J., Fuchs, J. R., Marcucci, G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.041 · Cited by 330
Sidhu, G. S., Mani, H., Gaddipati, J. P., Singh, A. K., Seth, P., Banaudha, K. K., Patnaik, G. K., & Maheshwari, R. K. (1999) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1999.00362.x · Cited by 330
Bharti, A. C., Shishodia, S., Reuben, J. M., Weber, D., Alexanian, R., Raj-Vadhan, S., Estrov, Z., Talpaz, M., & Aggarwal, B. B. (2004) · Blood · doi:10.1182/blood-2003-06-2151 · Cited by 318
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L.
TODA, S., MIYASE, T., ARICHI, H., TANIZAWA, H., & TAKINO, Y. (1985) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.33.1725 · Cited by 314
Curcumin is an Inhibitor of p300 Histone Acetylatransferase
Neckers, L., Trepel, J., Lee, S., Chung, E.-J., Lee, M.-J., Jung, Y.-J., & Marcu, M. (2006) · Medicinal Chemistry · doi:10.2174/157340606776056133 · Cited by 311
The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review
Miquel, J., Bernd, A., Sempere, J. M., Dı́az-Alperi, J., & Ramı́rez, A. (2002) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00194-7 · Cited by 309
Reddy, A. C. P., & Lokesh, B. R. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926033 · Cited by 309
Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice
Liu, M., Grigoryev, D. N., Crow, M. T., Haas, M., Yamamoto, M., Reddy, S. P., & Rabb, H. (2009) · Kidney International · doi:10.1038/ki.2009.157 · Cited by 304
Bao, B., Ali, S., Banerjee, S., Wang, Z., Logna, F., Azmi, A. S., Kong, D., Ahmad, A., Li, Y., Padhye, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2182 · Cited by 297
Shishodia, S., Potdar, P., Gairola, C. G., & Aggarwal, B. B. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg078 · Cited by 292
Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro
Schnaper, H. W., Grant, D. S., Stetler‐Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., French, D. L., et al. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041560204 · Cited by 289
Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B., & Fini, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10405 · Cited by 274
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Ceccacci, E., & Minucci, S. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.36 · Cited by 253
Phan, T.-T., See, P., Lee, S.-T., & Chan, S.-Y. (2001) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-200111000-00017 · Cited by 251
Cui, L., Miao, J., & Cui, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01238-06 · Cited by 248
Khor, T. O., Huang, Y., Wu, T.-Y., Shu, L., Lee, J., & Kong, A.-N. T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.065 · Cited by 245
Thayyullathil, F., Chathoth, S., Hago, A., Patel, M., & Galadari, S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.014 · Cited by 245
Role of curcumin in health and disease
Pari, L., Tewas, D., & Eckel, J. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802033958 · Cited by 245
Swarnakar, S., Ganguly, K., Kundu, P., Banerjee, A., Maity, P., & Sharma, A. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413398200 · Cited by 243
MicroRNAs in human cancer: from research to therapy
Negrini, M., Ferracin, M., Sabbioni, S., & Croce, C. M. (2007) · Journal of Cell Science · doi:10.1242/jcs.03450 · Cited by 239
Recent advances in the investigation of curcuminoids
Itokawa, H., Shi, Q., Akiyama, T., Morris-Natschke, S. L., & Lee, K.-H. (2008) · Chinese Medicine · doi:10.1186/1749-8546-3-11 · Cited by 237
He, H.-J. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i5.94 · Cited by 236
Shankar, S., & Srivastava, R. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.905 · Cited by 235
Inhibition of Proteasomal Function by Curcumin Induces Apoptosis through Mitochondrial Pathway
Jana, N. R., Dikshit, P., Goswami, A., & Nukina, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310369200 · Cited by 232
Neuroprotection by Curcumin in Ischemic Brain Injury Involves the Akt/Nrf2 Pathway
Wu, J., Li, Q., Wang, X., Yu, S., Li, L., Wu, X., Chen, Y., Zhao, J., & Zhao, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059843 · Cited by 228
Regulation of protein turnover by acetyltransferases and deacetylases
Sadoul, K., Boyault, C., Pabion, M., & Khochbin, S. (2008) · Biochimie · doi:10.1016/j.biochi.2007.06.009 · Cited by 222
Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
Yang, J., Cao, Y., Sun, J., & Zhang, Y. (2010) · Medical Oncology · doi:10.1007/s12032-009-9344-3 · Cited by 219
Soetikno, V., Sari, F. R., Veeraveedu, P. T., Thandavarayan, R. A., Harima, M., Sukumaran, V., Lakshmanan, A. P., Suzuki, K., Kawachi, H., & Watanabe, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-35 · Cited by 219
Control of metabolism by p53 – Cancer and beyond
Labuschagne, C. F., Zani, F., & Vousden, K. H. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.06.001 · Cited by 219
Thaloor, D., Miller, K. J., Gephart, J., Mitchell, P. O., & Pavlath, G. K. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.2.c320 · Cited by 212
MODULATION OF TRANSCRIPTION FACTORS BY CURCUMIN
Shishodia, S., Singh, T., & Chaturvedi, M. M. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_4 · Cited by 207
Li, X., Xie, W., Xie, C., Huang, C., Zhu, J., Liang, Z., Deng, F., Zhu, M., Zhu, W., Wu, R., et al. (2014) · Phytotherapy Research · doi:10.1002/ptr.5167 · Cited by 206
Curcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2
Meja, K. K., Rajendrasozhan, S., Adenuga, D., Biswas, S. K., Sundar, I. K., Spooner, G., Marwick, J. A., Chakravarty, P., Fletcher, D., Whittaker, P., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0012oc · Cited by 206
Curcumin Modulates MicroRNA-203–Mediated Regulation of the Src-Akt Axis in Bladder Cancer
Saini, S., Arora, S., Majid, S., Shahryari, V., Chen, Y., Deng, G., Yamamura, S., Ueno, K., & Dahiya, R. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0267 · Cited by 204
Liu, H.-L., Chen, Y., Cui, G.-H., & Zhou, J.-F. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00081.x · Cited by 203
Aggarwal, B. B., Van Kuiken, M. E., Iyer, L. H., Harikumar, K. B., & Sung, B. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-78 · Cited by 203
REGULATION OF COX AND LOX BY CURCUMIN
Rao, C. V. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_9 · Cited by 197
Li, Y., Kong, D., Wang, Z., & Sarkar, F. H. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0105-y · Cited by 190
Chen, Y., Shu, W., Chen, W., Wu, Q., Liu, H., & Cui, G. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00142.x · Cited by 187
Shu, L., Khor, T. O., Lee, J.-H., Boyanapalli, S. S. S., Huang, Y., Wu, T.-Y., Saw, C. L.-L., Cheung, K.-L., & Kong, A.-N. T. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9300-y · Cited by 187
Chemotherapeutic Potential of Curcumin for Colorectal Cancer
Chauhan, D. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394016 · Cited by 186
Kang, S.-K., Cha, S.-H., & Jeon, H.-G. (2006) · Stem Cells and Development · doi:10.1089/scd.2006.15.165 · Cited by 186
Kronski, E., Fiori, M. E., Barbieri, O., Astigiano, S., Mirisola, V., Killian, P. H., Bruno, A., Pagani, A., Rovera, F., Pfeffer, U., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.01.005 · Cited by 182
Yun, J.-M., Jialal, I., & Devaraj, S. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.03.014 · Cited by 182
González-Reyes, S., Guzmán-Beltrán, S., Medina-Campos, O. N., & Pedraza-Chaverri, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/801418 · Cited by 180
Shen, G., Xu, C., Hu, R., Jain, M. R., Gopalkrishnan, A., Nair, S., Huang, M.-T., Chan, J. Y., & Kong, A.-N. T. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0293 · Cited by 179
Bora-Tatar, G., Dayangaç-Erden, D., Demir, A. S., Dalkara, S., Yelekçi, K., & Erdem-Yurter, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.042 · Cited by 178
Fu, H., Wang, C., Yang, D., Wei, Z., Xu, J., Hu, Z., Zhang, Y., Wang, W., Yan, R., & Cai, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26190 · Cited by 178
Kuck, D., Singh, N., Lyko, F., & Medina-Franco, J. L. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.11.050 · Cited by 176
DNA-Binding of Drugs Used in Medicinal Therapies
Bischoff, G., & Hoffmann, S. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371085 · Cited by 175
Banerjee, S., Ji, C., Mayfield, J. E., Goel, A., Xiao, J., Dixon, J. E., & Guo, X. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806797115 · Cited by 174
Cell signaling pathways altered by natural chemopreventive agents
Sarkar, F. H., & Li, Y. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.04.015 · Cited by 172
Development of curcumin as an epigenetic agent
Fu, S., & Kurzrock, R. (2010) · Cancer · doi:10.1002/cncr.25414 · Cited by 170
Curcumin Modulates DNA Methylation in Colorectal Cancer Cells
Link, A., Balaguer, F., Shen, Y., Lozano, J. J., Leung, H.-C. E., Boland, C. R., & Goel, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057709 · Cited by 167
Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
Lee, S. J., Krauthauser, C., Maduskuie, V., Fawcett, P. T., Olson, J. M., & Rajasekaran, S. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-144 · Cited by 166
Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin.
Thaloor, D., Singh, A. K., Sidhu, G. S., Prasad, P. V., Kleinman, H. K., & Maheshwari, R. K. (1998) · PubMed · Cited by 165
Shao-Ling, W. A. N. G., Ying, L. I., Wen, Y., Yan-Feng, C. H. E. N., Na, L.-X., Li, S., & Sun, C. (2009) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(09)60019-2 · Cited by 164
Curcumin modulates free radical quenching in myocardial ischaemia in rats
Panchatcharam, M., Miriyala, S., Srinivasan, A., Manohar, B. M., Lokanadam, B., & Puvanakrishnan, R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.030 · Cited by 163
Bierhaus, A., Zhang, Y., Quehenberger, P., Luther, T., Haase, M., Müller, M., Mackman, N., Ziegler, R., & Nawroth, P. P. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656049 · Cited by 161
Yu, J., Peng, Y., Wu, L., Xie, Z., Deng, Y., Hughes, T. L., He, S., Mo, X. K., Chiu, M., Wang, Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055934 · Cited by 161
Dai, X., Liu, J., Zheng, H., Wichmann, J., Hopfner, U., Sudhop, S., Prein, C., Shen, Y., Machens, H.-G., & Schilling, A. F. (2017) · NPG Asia Materials · doi:10.1038/am.2017.31 · Cited by 161
Zhu, X., Li, Q., Chang, R., Yang, D., Song, Z., Guo, Q., & Huang, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091303 · Cited by 159
Zhang, J., Zhang, T., Ti, X., Shi, J., Wu, C., Ren, X., & Yin, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.013 · Cited by 158
Gao, S., Duan, X., Wang, X., Dong, D., Liu, D., Li, X., Sun, G., & Li, B. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.032 · Cited by 158
Jin, H., Lian, N., Zhang, F., Chen, L., Chen, Q., Lu, C., Bian, M., Shao, J., Wu, L., & Zheng, S. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.92 · Cited by 156
Curcumin Suppresses the Colon Cancer Proliferation by Inhibiting Wnt/β-Catenin Pathways via miR-130a
Dou, H., Shen, R., Tao, J., Huang, L., Shi, H., Chen, H., Wang, Y., & Wang, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00877 · Cited by 156
Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes
Gibbons, R. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi106 · Cited by 155
Kara, M., Yumrutaş, Ö., Özcan, Ö., Çelik, Ö. İ., Bozgeyik, E., Bozgeyik, İ., & Taşdemir, Ş. (2015) · Gene · doi:10.1016/j.gene.2015.04.065 · Cited by 152
Yang, C. H., Yue, J., Sims, M. M., & Pfeffer, L. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071130 · Cited by 148
Self-citationWatson, J. L., Greenshields, A. L., Hill, R., Hilchie, A. L., Lee, P. W. K., Giacomantonio, C. A., & Hoskin, D. W. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20571 · Cited by 148
Mackenzie, G. G., Queisser, N., Wolfson, M. L., Fraga, C. G., Adamo, A. M., & Oteiza, P. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23477 · Cited by 144
Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach
Medina‐Franco, J. L., López-Vallejo, F., Kuck, D., & Lyko, F. (2010) · Molecular Diversity · doi:10.1007/s11030-010-9262-5 · Cited by 143
Effect of Turmeric, Turmerin and Curcumin on H2O2-Induced Renal Epithelial (LLC-PK1) Cell Injury
Cohly, H., Taylor, A., Angel, M. F., et al. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00140-8 · Cited by 140
Toden, S., Okugawa, Y., Buhrmann, C., Nattamai, D., Anguiano, E., Baldwin, N. E., Shakibaei, M., Boland, C. R., & Goel, A. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0354 · Cited by 138
Quaglino, D., Nanney, L. B., Kennedy, R. Z., & Davidson, J. M. (1990) · PubMed · Cited by 137
Raynal, N. J. ‐., Si, J., Taby, R. F., Gharibyan, V., Ahmed, S., Jelı́nek, J., Estecio, M. R., & Issa, J. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3248 · Cited by 135
Liontas, A., & Yeger, H. (2004) · PubMed · Cited by 132
Das, L., & Vinayak, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124000 · Cited by 131
Mani, H., Sidhu, G. S., Kumari, R., Gaddipati, J. P., Seth, P., & Maheshwari, R. K. (2002) · BioFactors · doi:10.1002/biof.5520160104 · Cited by 131
Curcumin inhibits nitrogen dioxide induced oxidation of hemoglobin
Unnikrishnan, M. K., & Rao, M. N. A. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926878 · Cited by 122
Calabrese, V., Butterfield, D. A., & Stella, A. M. G. (2003) · PubMed · Cited by 121
Abusnina, A., Keravis, T. M., Yougbaré, I., Bronner, C., & Lugnier, C. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100307 · Cited by 113
Shin, D., Park, H.-M., Jung, K.-A., Choi, H.-G., Kim, J., Kim, D., Kim, S. G., Kang, K. W., Ku, S., Kensler, T. W., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.021 · Cited by 111
Prevention of ischaemia-induced biochemical changes by curcumin & quinidine in the cat heart.
Dikshit, M., Rastogi, L., Shukla, R., & Srimal, R. C. (1995) · PubMed · Cited by 110
Zheng, J., Wu, C., Lin, Z., Guo, Y. G., Shi, L., Dong, P., Lu, Z., Gao, S., Liao, Y., Chen, B., et al. (2013) · FEBS Journal · doi:10.1111/febs.12574 · Cited by 105
Curcumin Binding to DNA and RNA
Nafisi, S., Adelzadeh, M., Norouzi, Z., et al. (2009) · DNA and Cell Biology · doi:10.1089/dna.2008.0840 · Cited by 102
Evidence for dietary regulation of microRNA expression in cancer cells
Davis, C. D., & Ross, S. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00080.x · Cited by 101
Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis
Hahm, E., Gho, Y. S., Park, S., Park, C., Kim, K., & Yang, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.119 · Cited by 99
Self-citationShim, J. S., Kim, D. H., Jung, H. J., Kim, J. H., Lim, D., Lee, S., Kim, K.-W., Ahn, J. W., Yoo, J.-S., Rho, J., et al. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00129-3 · Cited by 97
Nirmala, C., & Puvanakrishnan, R. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02118-3 · Cited by 96
The functional genomic studies of curcumin
Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.002 · Cited by 96
Cheng, G., Yang, Z., Zhang, L., Wang, Y., Gong, W., & Liu, Y. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s147316 · Cited by 96
Curcumin Reactivates Silenced Tumor Suppressor Gene RARβ by Reducing DNA Methylation
Jiang, A., Wang, X., Shan, X., Li, Y., Wang, P., Jiang, P., & Feng, Q. (2015) · Phytotherapy Research · doi:10.1002/ptr.5373 · Cited by 94
Su, P., Yang, Y., Wang, G., Chen, X., & Ju, Y. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4461 · Cited by 94
Dietary Components Impact Histone Modifications and Cancer Risk
Davis, C. D., & Ross, S. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00285.x · Cited by 93
Reactivation of RASSF1A in Breast Cancer Cells by Curcumin
Du, L., Xie, Z., Wu, L., Chiu, M., Lin, J., Chan, K. K., Liu, S., & Liu, Z. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.717682 · Cited by 92
Reuter, S., Charlet, J., Juncker, T., Teiten, M.-H., Dicato, M. A., & Diederich, M. F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04731.x · Cited by 91
Jones, E. A., SHAHED, A. R., & Shoskes, D. A. (2000) · Urology · doi:10.1016/s0090-4295(00)00608-7 · Cited by 87
Rafiee, P., Nelson, V. M., Manley, S., Wellner, M. R., Floer, M., Binion, D. G., & Shaker, R. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90428.2008 · Cited by 87
Role of p53 isoforms and aggregations in cancer
Kim, S., & An, S. S. A. (2016) · Medicine · doi:10.1097/md.0000000000003993 · Cited by 85
AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells
Di (1994) · Oncology Reports · doi:10.3892/or_00000179 · Cited by 83
Jagetia, G. C., & Rajanikant, G. K. (2005) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000148372.75342.d9 · Cited by 81
Gaddipati, J. P., Sundar, S. V., Calemine, J., Seth, P., Sidhu, G. S., & Maheshwari, R. K. (2003) · Shock · doi:10.1097/00024382-200302000-00011 · Cited by 80
Jha, A. K., Nikbakht, M., Parashar, G., Shrivastava, A., Capalash, N., & Kaur, J. (2010) · Folia Biologica · doi:10.14712/fb2010056050195 · Cited by 80
Ogiwara, H., Ui, A., Shiotani, B., Zou, L., Yasui, A., & Kohno, T. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt240 · Cited by 78
Inhibition of histone acetylation by curcumin reduces alcohol-induced fetal cardiac apoptosis
Yan, X., Pan, B., Lv, T., Liu, L., Zhu, J., Shen, W., Huang, X., & Tian, J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-016-0310-z · Cited by 78
Chen, C., Yu, K., Yan, Q., Xing, C., Chen, Y., Yan, Z., Shi, Y., Zhao, K.-W., & Gao, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt070 · Cited by 76
Cohen, A. N., Veena, M. S., Srivatsan, E. S., & Wang, M. B. (2009) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.135.2.190 · Cited by 71
Kim, J. H., Shim, J. S., Lee, S., Kim, K., Rha, S. Y., Chung, H. C., & Kwon, H. J. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01247.x · Cited by 68
Induction of MicroRNA-9 Mediates Cytotoxicity of Curcumin Against SKOV3 Ovarian Cancer Cells
Zhao, S.-F., Zhang, X., Zhang, X., Shi, X., Yu, Z., & Kan, Q. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3363 · Cited by 66
Yang, H.-P. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.473 · Cited by 58
Gao, W., Chan, J. Y. W., & Wong, T. (2014) · Clinical Science · doi:10.1042/cs20140010 · Cited by 56
Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells
Rodríguez‐García, A., Hevia, D., Mayo, J. C., González‐Menéndez, P., Coppo, L., Lu, J., Holmgren, A., & Sainz, R. M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.025 · Cited by 55
Rafiee, P., Shi, Y., Pritchard, K. A., Ogawa, H., Eis, A., KOMOROWSKI, R. A., Fitzpatrick, C. M., Tweddell, J. S., Litwin, S. B., Mussatto, K. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212993200 · Cited by 53
Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4
Skommer, J., Włodkowic, D., & Pelkonen, J. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.09.006 · Cited by 49
Shim, J. S., Kim, D. H., Jung, H. J., Kim, J. H., Lim, D., Lee, S., Kim, K., Ahn, J. W., Yoo, J., Rho, J., et al. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00116-5 · Cited by 46
Devipriya, B., & Kumaradhas, P. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.05.002 · Cited by 34
Azad, G. K., Singh, V., Golla, U., & Tomar, R. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059003 · Cited by 33
Nirmala, C., Anand, S., & Puvanakrishnan, R. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006960106929 · Cited by 28
Li, W., Wang, Y., Song, Y., Xu, L., Zhao, J., & Fang, B. (2015) · Oncology Letters · doi:10.3892/ol.2015.2946 · Cited by 26
Curcumin-induced histone acetylation in malignant hematologic cells
Jun-bin, H., Wang, Y., & Chen, Y. (2009) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-009-0105-5 · Cited by 12
Effects of curcumin on proliferation of NB4 cells and acetylation of histone H3 and P53
Chen, Y., Li, X., & Wu, Q. (2004) · Chinese Journal of Cancer Research · doi:10.1007/s11670-004-0038-2 · Cited by 2
(2001) · PubMed
Cited by
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
Hashem, S., Ali, T. A., Akhtar, S., Nisar, S., Sageena, G., Ali, S., Al-Mannai, S., Therachiyil, L., Mir, R., Elfaki, I., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113054 · Cited by 377
Curcumin: Biological Activities and Modern Pharmaceutical Forms
Urošević, M., Nikolić, L., Gajić, I., Nikolić, V., Dinić, A., & Miljković, V. (2022) · Antibiotics · doi:10.3390/antibiotics11020135 · Cited by 347
Acetyl-CoA metabolism as a therapeutic target for cancer
Chen, G., Bao, B., Cheng, Y., Tian, M., Song, J., Zheng, L., & Tong, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115741 · Cited by 54
Inhibition of acetylation, is it enough to fight cancer?
López-Bañuelos, L., & Vega, L. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103752 · Cited by 32
Ayadilord, M., Nasseri, S., Emadian Razavi, F., Saharkhiz, M., Rostami, Z., & Naseri, M. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3659 · Cited by 30
Metadata
- Authors
- Hassan, F.-U., Rehman, M. S.-U., Khan, M. S., Ali, M. A., Javed, A., Nawaz, A., & Yang, C.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2019-06-04
- Volume
- 10
- Pages
- 514-514
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W2948525475
- Cited by
- 357
- References
- 185
- FWCI
- 11.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.